Anatomical and functional organization of cardiac fibers in the porcine cervical vagus nerve allows spatially selective efferent neuromodulation.
Nicole ThompsonEnrico RavagliSvetlana MastitskayaRonald ChallitaJoseph E HadayaFrancesco IacovielloAhmad Shah IdilPaul R ShearingOlujimi A AjijolaJeffrey L ArdellKalyanam ShivkumarDavid S HolderKirill Y AristovichPublished in: bioRxiv : the preprint server for biology (2024)
Cardiac disease progression reflects the dynamic interaction between adversely remodeled neurohumoral control systems and an abnormal cardiac substrate. Vagal nerve stimulation (VNS) is an attractive neuromodulatory option to dampen this dynamic interaction; however, it is limited by off-target effects. Spatially-selective VNS (sVNS) offers a promising solution to induce cardioprotection while mitigating off-target effects by specifically targeting pre-ganglionic parasympathetic efferent cardiac fibers. This approach also has the potential to enhance therapeutic outcomes by eliminating time-consuming titration required for optimal VNS. Recent studies have demonstrated the independent modulation of breathing rate, heart rate, and laryngeal contraction through sVNS. However, the spatial organization of afferent and efferent cardiac-related fibers within the vagus nerve remains unexplored. By using trial-and-error sVNS in vivo in combination with ex vivo micro-computed tomography fascicle tracing, we show the significant spatial separation of cardiac afferent and efferent fibers (179±55° SD microCT, p<0.05 and 200±137° SD, p<0.05 sVNS - degrees of separation across a cross-section of nerve) at the mid-cervical level. We also show that cardiac afferent fibers are located in proximity to pulmonary fibers consistent with recent findings of cardiopulmonary convergent neurons and circuits. We demonstrate the ability of sVNS to selectively elicit desired scalable heart rate decrease without stimulating afferent-related reflexes. By elucidating the spatial organization of cardiac-related fibers within the vagus nerve, our findings pave the way for more targeted neuromodulation, thereby reducing off-target effects and eliminating the need for titration. This, in turn, will enhance the precision and efficacy of VNS therapy in treating cardiac pathology, allowing for improved therapeutic efficacy.
Keyphrases
- heart rate
- left ventricular
- computed tomography
- heart rate variability
- randomized controlled trial
- heart failure
- magnetic resonance imaging
- metabolic syndrome
- atrial fibrillation
- pulmonary hypertension
- skeletal muscle
- spinal cord injury
- mesenchymal stem cells
- drug delivery
- type diabetes
- cancer therapy
- mass spectrometry
- climate change
- weight loss
- bone marrow
- cell therapy